First Trust NASDAQ 100 Technology Index Fund vs Roivant Sciences Ltd. Common Shares — how do they compare? First Trust NASDAQ 100 Technology Index Fund trades at $333 (market cap $4.15B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 6× First Trust NASDAQ 100 Technology Index Fund's market cap, and First Trust NASDAQ 100 Technology Index Fund is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold First Trust NASDAQ 100 Technology Index Fund for 40 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| QTEC | ROIV | |
|---|---|---|
Market Cap | $4.15B | $25.09B |
Volume | 278,646 | 5,738,571 |
Sector | Broad Market / Factor | Health |
52-Week High | $340.28 | $41.81 |
52-Week Low | $207.03 | $16.04 |
Typical Hold Time | 40 Days | 0 Days |
Enterprise Value | — | $21.36B |
Signals from Pluang's Aura AI — not financial advice
QTEC trades at $335.82, down 1.31% today, with a bullish technical signal from moving averages but bearish oscillators. The ETF provides equal-weighted exposure to NASDAQ-100 technology stocks, offering diversification across software and hardware sectors. Recent analysis highlights software industry undervaluation relative to historical averages, positioning QTEC as a liquid alternative to similar funds.
The outlook remains cautiously optimistic given technology sector growth potential, though overbought RSI levels suggest near-term consolidation. Key risks include sector volatility and macroeconomic pressures on tech valuations, while institutional interest supports long-term stability.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.
Read more on QTEC →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →